Seamless gene correction of beta-thalassemia mutations in patient-specific cells
A major hurdle in gene therapy is the efficient integration of a corrected gene into a patient's genome without mutating off-target sites. In a paper published today in Genome Research, scientists have used CRISPR/Cas genome ...
Aug 5, 2014
0
0